サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1756491

RSV診断市場：製品別、方法別、エンドユーザー別、国別、地域別-2024～2032年の産業分析、市場規模、市場シェア、予測

RSV Diagnostics Market, By Product, By Method, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 356 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.80円
RSV診断市場：製品別、方法別、エンドユーザー別、国別、地域別-2024～2032年の産業分析、市場規模、市場シェア、予測
出版日: 2025年05月23日
発行: AnalystView Market Insights
ページ情報: 英文 356 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

RSV診断市場規模は2024年に6兆4,566億7,000万米ドルとなり、2024～2032年にかけてCAGR 5.87%で拡大

RSV診断市場-市場力学

呼吸器感染症の有病率の増加

呼吸器感染症、特に乳幼児、高齢者、免疫不全患者の罹患率の増加は、RSV診断市場の主要な促進要因です。呼吸器合胞体ウイルス（RSV）は、世界中で下気道感染症の主要原因となっており、入院やヘルスケアコストに大きな影響を与えています。先進的RSV診断ツールによる早期かつ正確な診断は、タイムリーな治療に役立ち、感染の拡大を抑えます。さらに、ヘルスケア提供者の意識の高まりと診断技術へのアクセスの向上が、市場の成長をさらに後押ししています。これらの要因が相まって、効率的で迅速なRSV診断ソリューションに対する需要が世界的に高まっています。

RSV診断市場-主要な洞察

当社のリサーチアナリストによると、世界のRSV診断市場は、2024～2032年の間に約5.87%のCAGRで発展する見込みです。

2024年の製品別セグメントでは、キットとアッセイのカテゴリーが市場を独占しています。

エンドユーザー別では、2024年に最も収益を上げたのは病院クリニックセグメントでした。

地域別では、2024年に北米が最も高い収益を上げた地域でした。

RSV診断市場-セグメンテーション分析

世界のRSV診断市場は4つのカテゴリーに分けられます：製品、方法、エンドユーザー、地域です。

製品別では、RSV診断市場はキットとアッセイ、機器、その他の製品に区分されます。キットとアッセイには、患者サンプル中のRSV抗原または核酸を検出するための試薬と検査キットが含まれます。機器とは、PCR装置やイムノアッセイリーダーなど、診断検査を行うための装置や分析装置を指します。その他の製品には、検査に必要な消耗品や付属品が含まれます。これらのセグメントの中で、キットとアッセイが圧倒的なシェアを占めているのは、迅速かつ正確な結果を提供するという重要な役割を担っているからです。利便性、使いやすさ、アッセイ技術の進歩により、病院、クリニック、診断ラボでのキットの採用が進んでおり、このセグメントがRSV診断市場で最大の売上貢献要因となっています。

エンドユーザー別では、RSV診断市場は病院とクリニック、臨床検査室、在宅医療に区分されます。病院クリニックは患者が直接診断・治療を受ける医療施設で、呼吸器疾患の症例が多いです。臨床検査室は、先進的機器と熟練したスタッフによる診断検査の実施を専門とし、複数の医療提供者にサービスを提供しています。在宅医療は、従来型医療環境外で利便性と早期発見を提供する在宅検査ソリューションです。これらのうち、病院とクリニックは、特に呼吸器感染症が急増するRSVシーズン中、患者ケアの最前線で役割を果たすため、市場を独占しています。発生を管理し、即座に治療を提供するために、迅速で正確な診断が必要とされ、RSV診断製品に対する大きな需要を牽引しており、市場において最大かつ最も影響力のあるエンドユーザーセグメントとなっています。

RSV診断市場-地理的洞察

地域的には、RSV診断市場は北米、アジア太平洋、ラテンアメリカ、欧州、中東・アフリカに分布しています。これらの地域は、ビジネスをもたらす国々に基づいてさらに分割されます。

北米はRSV診断市場において支配的な地位を占めており、これは先進的ヘルスケアインフラ、革新的な診断技術の普及、高い医療費に牽引されています。同地域では、特に乳幼児や高齢者の間でRSV感染の負担が大きく、正確で迅速な検査に対する需要が高まっています。さらに、政府の強力な支援、確立された償還施策、大手市場参入企業の存在が、市場の堅調な成長に寄与しています。RSV早期診断の重要性に対するヘルスケアプロバイダや患者の意識の高まりが、北米市場の拡大をさらに後押ししています。

アジア太平洋はRSV診断市場のもう一つの支配的な地域であり、患者数の多さと呼吸器感染症の罹患率の上昇に後押しされています。急速な都市化、ヘルスケア施設の改善、医療インフラへの投資の増加がRSV診断ソリューションの採用を促進しています。中国、インド、日本などの国々は、感染症と闘うための政府のイニシアチブの高まりに支えられ、主要な貢献国となっています。さらに、都市部と農村部の両方における診断検査に対する認識とアクセシビリティの向上が市場成長の原動力となっており、アジア太平洋は世界のRSV診断市場において重要かつ急成長しているセグメントとなっています。

RSV診断市場-競合情勢

RSV診断市場は、確立された診断企業と、精度の向上と迅速な検出を重視する革新的な新規参入企業によって形成されています。Abbott、Roche、Thermo Fisher、Becton Dickinsonなどの主要企業は、高品質の診断キット、機器、アッセイを幅広く提供し、市場を独占しています。これらの企業は、検査感度の向上、所要時間の短縮、厳格な規制基準の遵守のため、研究開発に多額の投資を行っています。新興企業は新しい分子検査やポイントオブケア検査ソリューションを導入し、競合を激化させています。このような動きが継続的な技術革新を促し、病院、クリニック、検査室でのRSV診断の採用を拡大し、呼吸器感染症管理を世界的に改善しています。

目次

第1章 RSV診断市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 RSV診断の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 RSV診断産業の研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長展望マッピング
  • 規制枠組み分析

第5章 RSV診断市場： COVID-19の影響分析

  • COVID-19前の影響分析
  • COVID-19後の影響分析

第6章 RSV診断市場情勢

  • RSV診断市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • ベテラン選手の分析
    • 新興企業の分析

第7章 RSV診断市場-製品別

  • 概要
    • 製品別セグメントシェア分析
    • キットとアッセイ
    • 機器
    • その他

第8章 RSV診断市場-方法別

  • 概要
    • 方法別セグメントシェア分析
    • 分子診断
    • 迅速抗原検出検査
      • 酵素結合免疫吸着法
      • 免疫蛍光アッセイ
      • その他の迅速抗原検出検査
      • クロマトグラフィー免疫測定
      • 光学免疫測定
    • その他の方法

第9章 RSV診断市場-エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 病院とクリニック
    • 臨床検査室
    • 在宅医療

第10章 RSV診断市場-地域

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • 英国
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 韓国
    • 日本
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析-RSV診断産業

  • 競合ダッシュボード
  • 企業プロファイル
    • Biomerieux
    • Becton, Dickinson and Company（BD）
    • Abbott
    • Roche
    • Danaher
    • Thermo Fisher
    • Biocartis
    • Luminex
    • Hologic
    • Fast Track Diagnostics
    • その他

第12章 アナリストの全方位展望

目次
Product Code: ANV5247

REPORT HIGHLIGHT

RSV Diagnostics Market size was valued at USD 6,456.67 Billion in 2024, expanding at a CAGR of 5.87% from 2024 to 2032.

Respiratory Syncytial Virus (RSV) diagnostics involve detecting the presence of RSV infection in patients, primarily through respiratory samples like nasal swabs. The main diagnostic methods include nucleic acid amplification tests (NAATs) such as real-time PCR, which are highly sensitive and specific, rapid antigen detection tests (RADTs) that provide quicker but sometimes less accurate results, and viral culture, which is slower and less commonly used. Accurate detection is crucial for timely treatment and infection control, especially in infants and elderly patients vulnerable to severe RSV disease. Testing is usually performed within the early days of symptom onset to ensure reliability.

RSV Diagnostics Market- Market Dynamics

Increasing Prevalence of Respiratory Infections

The rising incidence of respiratory infections, particularly among infants, elderly individuals, and immunocompromised patients, is a major driver for the RSV diagnostics market. Respiratory Syncytial Virus (RSV) is a leading cause of lower respiratory tract infections worldwide, resulting in significant hospitalizations and healthcare costs. Early and accurate diagnosis through advanced RSV diagnostic tools helps in timely treatment and reduces the spread of infection. Additionally, growing awareness among healthcare providers and improved access to diagnostic technologies further fuel market growth. These factors collectively boost demand for efficient and rapid RSV diagnostic solutions globally.

RSV Diagnostics Market- Key Insights

According to our research analyst, the global RSV Diagnostics Market is expected to develop at a CAGR of approximately 5.87% between 2024-2032.

Segmented by Product in 2024, the Kits and Assays category dominated the market.

Based on End User, the Hospitals and Clinics segment generated the most income in 2024.

On the basis of region, in 2024, North America was the region with the highest revenue.

RSV Diagnostics Market- Segmentation Analysis:

The global RSV Diagnostics Market is divided into Four categories: Product, Method, End User and Region.

By product, the RSV diagnostics market is segmented into Kits and Assays, Instruments, and Other Products. Kits and Assays include reagents and test kits used for detecting RSV antigens or nucleic acids in patient samples. Instruments refer to the devices and analyzers used to perform diagnostic tests, such as PCR machines and immunoassay readers. Other Products encompass consumables and accessories required during testing. Among these segments, Kits and Assays hold the dominant share due to their critical role in providing rapid and accurate results, which are essential for timely clinical decision-making. The convenience, ease of use, and advancements in assay technologies have driven strong adoption of kits across hospitals, clinics, and diagnostic laboratories, making this segment the largest revenue contributor in the RSV diagnostics market.

By end user, the RSV diagnostics market is segmented into Hospitals and Clinics, Clinical Laboratories, and Home Care. Hospitals and Clinics represent healthcare facilities where patients receive diagnosis and treatment directly, often handling a high volume of respiratory cases. Clinical Laboratories specialize in conducting diagnostic tests with advanced equipment and skilled personnel, serving multiple healthcare providers. Home Care involves at-home testing solutions that offer convenience and early detection outside traditional healthcare settings. Among these, Hospitals and Clinics dominate the market due to their frontline role in patient care, especially during RSV seasons when respiratory infections surge. Their need for rapid, accurate diagnostics to manage outbreaks and provide immediate treatment drives substantial demand for RSV diagnostic products, making them the largest and most influential end-user segment in the market.

RSV Diagnostics Market- Geographical Insights

Geographically, the RSV Diagnostics Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America holds a dominant position in the RSV diagnostics market, driven by advanced healthcare infrastructure, widespread adoption of innovative diagnostic technologies, and high healthcare spending. The region experiences a significant burden of RSV infections, especially among infants and elderly populations, increasing demand for accurate and rapid testing. Additionally, strong government support, well-established reimbursement policies, and presence of leading market players contribute to robust market growth. The growing awareness among healthcare providers and patients about the importance of early RSV diagnosis further fuels the expansion of the market in North America.

Asia Pacific is another dominant region in the RSV diagnostics market, propelled by a large patient population and rising incidence of respiratory infections. Rapid urbanization, improving healthcare facilities, and increasing investments in healthcare infrastructure enhance the adoption of RSV diagnostic solutions. Countries such as China, India, and Japan are key contributors, supported by growing government initiatives to combat infectious diseases. Additionally, increasing awareness and accessibility to diagnostic testing in both urban and rural areas are driving market growth, making Asia Pacific a critical and fast-growing segment in the global RSV diagnostics landscape.

RSV Diagnostics Market- Competitive Landscape:

The RSV diagnostics market is shaped by established diagnostics firms and innovative newcomers focusing on enhanced accuracy and rapid detection. Key players such as Abbott, Roche, Thermo Fisher, and Becton Dickinson dominate the market with a wide range of high-quality diagnostic kits, instruments, and assays. These companies invest heavily in R&D to improve test sensitivity, reduce turnaround time, and comply with stringent regulatory standards. Emerging companies are introducing novel molecular and point-of-care testing solutions, increasing competition. This dynamic fosters continuous innovation, expanding the adoption of RSV diagnostics across hospitals, clinics, and laboratories, thereby improving respiratory infection management globally.

Recent Developments:

In April 2024, Abbott launched a next-generation point-of-care molecular test for RSV and influenza, delivering faster and more accurate respiratory infection diagnosis to support better patient outcomes in diverse clinical settings.

In June 2023, BD completed the sale of its surgical instruments and laparoscopic instrumentation business to STERIS plc, streamlining its portfolio to focus on core diagnostic and medical device segments.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RSV DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Biomerieux
  • Becton, Dickinson and Company (BD)
  • Abbott
  • Roche
  • Danaher
  • Thermo Fisher
  • Biocartis
  • Luminex
  • Hologic
  • Fast Track Diagnostics
  • Others

GLOBAL RSV DIAGNOSTICS MARKET, BY PRODUCT - MARKET ANALYSIS, 2019 - 2032

  • Kits and Assays
  • Instruments
  • Other Products

GLOBAL RSV DIAGNOSTICS MARKET, BY METHOD - MARKET ANALYSIS, 2019 - 2032

  • Molecular Diagnostics
  • Rapid Antigen Detection Tests
  • Enzyme-Linked Immunosorbent Assays
  • Immunofluorescence Assays
  • Other Rapid Antigen Detection Tests
  • Chromatographic Immunoassays
  • Optical Immunoassays
  • Other Methods

GLOBAL RSV DIAGNOSTICS MARKET, BY END USER - MARKET ANALYSIS, 2019 - 2032

  • Hospitals and Clinics
  • Clinical Laboratories
  • Home Care

GLOBAL RSV DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. RSV Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. RSV Diagnostics Market Snippet by Product
    • 2.1.2. RSV Diagnostics Market Snippet by Method
    • 2.1.3. RSV Diagnostics Market Snippet by End User
    • 2.1.4. RSV Diagnostics Market Snippet by Country
    • 2.1.5. RSV Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. RSV Diagnostics Key Market Trends

  • 3.1. RSV Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. RSV Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. RSV Diagnostics Market Opportunities
  • 3.4. RSV Diagnostics Market Future Trends

4. RSV Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. RSV Diagnostics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. RSV Diagnostics Market Landscape

  • 6.1. RSV Diagnostics Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. RSV Diagnostics Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
    • 7.1.2. Kits and Assays
    • 7.1.3. Instruments
    • 7.1.4. Other Products

8. RSV Diagnostics Market - By Method

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Method, 2023 & 2032 (%)
    • 8.1.2. Molecular Diagnostics
    • 8.1.3. Rapid Antigen Detection Tests
      • 8.1.3.1. Enzyme-Linked Immunosorbent Assays
      • 8.1.3.2. Immunofluorescence Assays
      • 8.1.3.3. Other Rapid Antigen Detection Tests
      • 8.1.3.3.1. Chromatographic Immunoassays
      • 8.1.3.3.2. Optical Immunoassays
    • 8.1.4. Other Methods

9. RSV Diagnostics Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2. Hospitals and Clinics
    • 9.1.3. Clinical Laboratories
    • 9.1.4. Home Care

10. RSV Diagnostics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. RSV Diagnostics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. RSV Diagnostics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. France
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.4. France Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.3.8.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. Italy
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.4. Italy Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.3.9.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. Spain
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.4. United Kingdom Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.3.10.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. United Kingdom
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.4. United Kingdom Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.3.11.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Russia
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Russia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Netherlands
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Netherlands Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Sweden
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Sweden Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. RSV Diagnostics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. South Korea
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.4. South Korea Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.4.9.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. Japan
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.4. Japan Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.4.10.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. RSV Diagnostics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. RSV Diagnostics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- RSV Diagnostics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Biomerieux
    • 11.2.2. Becton, Dickinson and Company (BD)
    • 11.2.3. Abbott
    • 11.2.4. Roche
    • 11.2.5. Danaher
    • 11.2.6. Thermo Fisher
    • 11.2.7. Biocartis
    • 11.2.8. Luminex
    • 11.2.9. Hologic
    • 11.2.10. Fast Track Diagnostics
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us